tradingkey.logo
tradingkey.logo
Search

Yuyu Pharma CEO Robert Wonsang Yu Launches "Robert's YUniverse" Podcast

PR NewswireSep 9, 2026 1:00 PM
facebooktwitterlinkedin
View all comments0

SEOUL, South Korea, Sept. 9, 2026 /PRNewswire/ -- Robert Wonsang Yu, CEO of Yuyu Pharma, has launched "Robert's YUniverse", a new podcast series featuring conversations with guests from across culture, business and animal health.

Hosted by Robert Wonsang Yu, the podcast explores subjects including Korean culture, Korean cuisine and global business insights. The series also places a particular focus on pet health, with discussions on topics such as veterinary biotechnology and cat wellness.

Early episodes feature interviews with international experts from the animal health industry, academia and the veterinary field. Conversations focus on recent research findings, emerging technologies and practical ideas expected to shape the future of animal health.

"I want 'Robert's YUniverse' to be a place where I can meet interesting people from a wide range of fields, ask questions and share what I learn," said Robert Wonsang Yu, CEO of Yuyu Pharma. "The show will go beyond pharmaceuticals and biotechnology to explore Korea and Asia, as well as food, travel and pets."

About Yuyu Pharma

Founded in 1941, Yuyu Pharma (KRX: 000220) is a Korea-based healthcare company focused on pharmaceuticals, medical devices, and health supplements that improve quality of life. As part of its global growth strategy, the company invests in early-stage and high-growth innovators across biotechnology, sustainability, and animal health through Yuyu Venture Studio.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.